Expanding the Role of Complement Therapies: The Case for Lupus Nephritis

• Published in: Journal of clinical medicine Vol. 10; no. 4; p. 626
• Main Authors: Li, Nicholas L., Birmingham, Daniel J., Rovin, Brad H.
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 07.02.2021; MDPI
• Subjects: Antigens; Autoimmune diseases; Binding sites; Clinical medicine; Disease; Lectins; Lupus; Pathogens; Proteins; Review; lupus nephritis; systemic lupus erythematosus; complement; glomerulonephritis
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm10040626

The complement system is an innate immune surveillance network that provides defense against microorganisms and clearance of immune complexes and cellular debris and bridges innate and adaptive immunity. In the context of autoimmune disease, activation and dysregulation of complement can lead to uncontrolled inflammation and organ damage, especially to the kidney. Systemic lupus erythematosus (SLE) is characterized by loss of tolerance, autoantibody production, and immune complex deposition in tissues including the kidney, with inflammatory consequences. Effective clearance of immune complexes and cellular waste by early complement components protects against the development of lupus nephritis, while uncontrolled activation of complement, especially the alternative pathway, promotes kidney damage in SLE. Therefore, complement plays a dual role in the pathogenesis of lupus nephritis. Improved understanding of the contribution of the various complement pathways to the development of kidney disease in SLE has created an opportunity to target the complement system with novel therapies to improve outcomes in lupus nephritis. In this review, we explore the interactions between complement and the kidney in SLE and their implications for the treatment of lupus nephritis.